FR2986156B1 - Dispositif transdermique pour l'administration controlee a un patient d'au moins un principe actif - Google Patents

Dispositif transdermique pour l'administration controlee a un patient d'au moins un principe actif

Info

Publication number
FR2986156B1
FR2986156B1 FR1250851A FR1250851A FR2986156B1 FR 2986156 B1 FR2986156 B1 FR 2986156B1 FR 1250851 A FR1250851 A FR 1250851A FR 1250851 A FR1250851 A FR 1250851A FR 2986156 B1 FR2986156 B1 FR 2986156B1
Authority
FR
France
Prior art keywords
transdermic
patient
active ingredient
controlled administration
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1250851A
Other languages
English (en)
Other versions
FR2986156A1 (fr
Inventor
Michel Faupel
Serge Bischoff
Florian George
Peter Stark
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RHENOVIA PHARMA
Original Assignee
RHENOVIA PHARMA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR1250851A priority Critical patent/FR2986156B1/fr
Application filed by RHENOVIA PHARMA filed Critical RHENOVIA PHARMA
Priority to KR1020147021691A priority patent/KR20140116898A/ko
Priority to CN201380007389.6A priority patent/CN104244924A/zh
Priority to PCT/FR2013/000028 priority patent/WO2013114011A1/fr
Priority to RU2014133757A priority patent/RU2014133757A/ru
Priority to EP13712825.2A priority patent/EP2809302A1/fr
Priority to JP2014553775A priority patent/JP2015511832A/ja
Priority to CA2861527A priority patent/CA2861527A1/fr
Priority to US14/373,923 priority patent/US9782482B2/en
Publication of FR2986156A1 publication Critical patent/FR2986156A1/fr
Application granted granted Critical
Publication of FR2986156B1 publication Critical patent/FR2986156B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/0626—Monitoring, verifying, controlling systems and methods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/065—Light sources therefor
    • A61N2005/0651—Diodes
    • A61N2005/0652—Arrays of diodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Radiation-Therapy Devices (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
FR1250851A 2012-01-30 2012-01-30 Dispositif transdermique pour l'administration controlee a un patient d'au moins un principe actif Expired - Fee Related FR2986156B1 (fr)

Priority Applications (9)

Application Number Priority Date Filing Date Title
FR1250851A FR2986156B1 (fr) 2012-01-30 2012-01-30 Dispositif transdermique pour l'administration controlee a un patient d'au moins un principe actif
CN201380007389.6A CN104244924A (zh) 2012-01-30 2013-01-30 用于向患者受控给药至少一种活性成分的透皮装置
PCT/FR2013/000028 WO2013114011A1 (fr) 2012-01-30 2013-01-30 Dispositif transdermioue pour l'administration contrôlée a un patient d'au moins un principe actif
RU2014133757A RU2014133757A (ru) 2012-01-30 2013-01-30 Прибор для управляемого введения пациенту через кожу по крайней мере одного активного ингредиента
KR1020147021691A KR20140116898A (ko) 2012-01-30 2013-01-30 환자에 적어도 하나의 활성 성분을 조절 투여하기 위한 경피용 장치
EP13712825.2A EP2809302A1 (fr) 2012-01-30 2013-01-30 Dispositif transdermioue pour l'administration contrôlée a un patient d'au moins un principe actif
JP2014553775A JP2015511832A (ja) 2012-01-30 2013-01-30 少なくとも１つの有効成分を制御して患者に投与するための経皮投与装置
CA2861527A CA2861527A1 (fr) 2012-01-30 2013-01-30 Dispositif transdermioue pour l'administration controlee a un patient d'au moins un principe actif
US14/373,923 US9782482B2 (en) 2012-01-30 2013-01-30 Transdermal device for the controlled administration of at least one active ingredient to a patient

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1250851A FR2986156B1 (fr) 2012-01-30 2012-01-30 Dispositif transdermique pour l'administration controlee a un patient d'au moins un principe actif

Publications (2)

Publication Number Publication Date
FR2986156A1 FR2986156A1 (fr) 2013-08-02
FR2986156B1 true FR2986156B1 (fr) 2014-07-04

Family

ID=48014039

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1250851A Expired - Fee Related FR2986156B1 (fr) 2012-01-30 2012-01-30 Dispositif transdermique pour l'administration controlee a un patient d'au moins un principe actif

Country Status (9)

Country Link
US (1) US9782482B2 (fr)
EP (1) EP2809302A1 (fr)
JP (1) JP2015511832A (fr)
KR (1) KR20140116898A (fr)
CN (1) CN104244924A (fr)
CA (1) CA2861527A1 (fr)
FR (1) FR2986156B1 (fr)
RU (1) RU2014133757A (fr)
WO (1) WO2013114011A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015027018A1 (fr) * 2013-08-21 2015-02-26 Senseonics, Incorporated Élution de médicaments pour protection in vivo d'analytes biocapteurs
FR3034023B1 (fr) * 2015-03-23 2021-01-08 Lucibel Dispositif de traitement cutane
FR3034021B1 (fr) * 2015-03-23 2021-01-08 Lucibel Dispositif de phototherapie deformable
US10596388B2 (en) 2016-09-21 2020-03-24 Epistar Corporation Therapeutic light-emitting module
TWI714347B (zh) * 2017-11-14 2020-12-21 美商伊英克加利福尼亞有限責任公司 包含多孔導電電極層之電泳主動遞送系統
WO2021108210A1 (fr) 2019-11-27 2021-06-03 E Ink California, Llc Système de distribution d'agent bénéfique comprenant des microcellules ayant une couche d'étanchéité à électro-érosion
US20240245892A1 (en) * 2021-10-22 2024-07-25 Georgetown University Non-Invasive and Passive Transdermal Drug Delivery Patch For Parkinson's Disease
PL4205808T3 (pl) * 2021-12-30 2026-04-13 Paul Hartmann Ag Urządzenie do przeciwdrobnoustrojowego leczenia ran
ES3060390T3 (en) * 2021-12-30 2026-03-26 Hartmann Paul Ag Wound dressing for antimicrobial wound treatment

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU662531B2 (en) * 1991-06-12 1995-09-07 Mcneil-Ppc, Inc. Melt blown menstrual pad for application to the body
US5464387A (en) * 1991-07-24 1995-11-07 Alza Corporation Transdermal delivery device
US5462743A (en) * 1992-10-30 1995-10-31 Medipro Sciences Limited Substance transfer system for topical application
CA2187023A1 (fr) * 1994-04-13 1995-10-26 Steven Andrew Giannos Systemes d'administration de medicaments, a liberation controlee dans le temps
CA2432438C (fr) * 2001-01-09 2011-04-26 Microchips, Inc. Dispositifs flexibles a micropuces a usage ophtalmique ou autre
CN2533890Y (zh) * 2002-02-11 2003-02-05 叶延程 药物透皮控释装置
US20040122500A1 (en) * 2002-12-19 2004-06-24 Kimberly-Clark Worldwide, Inc. Electrode for utilizing edge effect to create uniform current density
WO2004060447A2 (fr) * 2002-12-31 2004-07-22 Ultra-Sonic Technologies, L.L.C. Administration par voie transdermique utilisant un agent encapsule active par les ultrasons et/ou la chaleur
WO2006015299A2 (fr) * 2004-07-30 2006-02-09 Microchips, Inc. Dispositif multi-reservoir pour la delivrance de medicament transdermique et la detection
US20060173514A1 (en) * 2005-02-02 2006-08-03 Advanced Photodynamic Technologies, Inc. Wound treatment device for photodynamic therapy and method of using same
US8936590B2 (en) * 2005-11-09 2015-01-20 The Invention Science Fund I, Llc Acoustically controlled reaction device
DE102006023186B4 (de) * 2006-05-17 2012-02-23 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Transdermales therapeutisches System
US20080058907A1 (en) * 2006-08-30 2008-03-06 Reuben David I Self Sanitizing Bandage with Built-In Ultraviolet LED
US7666179B2 (en) * 2006-10-10 2010-02-23 Boston Scientific Scimed, Inc. Medical devices having porous regions for controlled therapeutic agent exposure or delivery
US8206326B2 (en) * 2008-03-04 2012-06-26 Sound Surgical Technologies, Llc Combination ultrasound-phototherapy transducer
GB0821862D0 (en) * 2008-12-01 2009-01-07 Lumicure Ltd Light Emitting apparatus
US8163834B2 (en) * 2009-03-18 2012-04-24 Dublin City University Photoresponsive ionogel
KR101906132B1 (ko) * 2010-07-17 2018-10-10 메르크 파텐트 게엠베하 침투 및 작용의 증진
US9289584B2 (en) * 2010-09-13 2016-03-22 The University Of British Columbia Remotely controlled drug delivery systems
GB2505796A (en) * 2011-05-14 2014-03-12 Lucifics Inc Phototherapy system

Also Published As

Publication number Publication date
EP2809302A1 (fr) 2014-12-10
US20150018749A1 (en) 2015-01-15
RU2014133757A (ru) 2016-03-20
US9782482B2 (en) 2017-10-10
CA2861527A1 (fr) 2013-08-08
JP2015511832A (ja) 2015-04-23
KR20140116898A (ko) 2014-10-06
WO2013114011A8 (fr) 2014-08-28
WO2013114011A1 (fr) 2013-08-08
FR2986156A1 (fr) 2013-08-02
CN104244924A (zh) 2014-12-24

Similar Documents

Publication Publication Date Title
EP2670458A4 (fr) Dispositif d'administration de médicament
EP2768571A4 (fr) Dispositif médical d'administration de médicament
EP2968071A4 (fr) Dispositif pour l'administration orale de composés thérapeutiques
EP2991711A4 (fr) Dispositif d'administration de médicament
EP2544741A4 (fr) Dispositif d'administration de médicament
EP2526986A4 (fr) Dispositif d'administration de médicament
EP2627382A4 (fr) Dispositif d'administration de médicament
EP2812069A4 (fr) Dispositif d'administration transdermique
EP2670439A4 (fr) Principe actif destiné à atténuer des troubles médicaux indésirables
EP2717813A4 (fr) Dispositif d'administration de médicament employant une fenêtre de libération par inhibition par capillarité
EP2593039A4 (fr) Dispositif médical d'administration de médicament
EP2680913A4 (fr) Dispositif d'administration de médicament par voie nasale
EP2846772A4 (fr) Préparations de dépôt d'un principe actif hydrophobe et procédés de préparation associés
MA41818A (fr) Timbre à micro-aiguilles pour administration d'un principe actif à la peau
EP2720743A4 (fr) Masque pour l'administration de médicament inhalé
IT1403780B1 (it) Dispositivo per l'infusione di farmaci.
EP3824925C0 (fr) Dispositif d'administration de médicaments
EP2667857A4 (fr) Dispositif d'administration de médicament
EP2896022A4 (fr) Régulateur d'administration de médicaments
EP2792746A4 (fr) Oligonucléotide anisi qu'agent thérapeutique pour l'hyperlipidémie contenant cet oligonucléotide en tant que principe actif
EP2869784A4 (fr) Appareil oral pour l'administration d'un médicament
EP2643020A4 (fr) Dispositif d'administration de médicament
EP2623100A4 (fr) Préparation pour améliorer la solubilité d'un médicament médiocrement soluble
EP2649979A4 (fr) Dispositif d'alimentation d'un médicament
EP2943235A4 (fr) Soupape actionnée par l'écoulement pour dispositif d'administration de médicament implantable

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

ST Notification of lapse

Effective date: 20180928